Author Archive | Yali Friedman

For success in biotechnology, look beyond biotechnology

Many biotechnology entrepreneurs favorably look back at times when financing and regulatory approval were easier to obtain. While future periods of investor exuberance may return, it is better to see these as market aberrations. In periods of investor exuberance companies have been pushed to focus on low-probability, high-return, objectives such as approval and successful marketing […]

Continue Reading

New Book – Biotechnology Entrepreneurship: From Science to Solutions

I’ve just published a new book, by Michael L. Salgaller, PhD. In Biotechnology Entrepreneurship: From Science to Solutions Michael combines the voices of a diverse set of industry insiders with extensive experience in biotechnology commercialization to prepares nascent founders, managers, investors, and other biotechnology company stakeholders to position themselves and their companies for commercial success. […]

Continue Reading

Synthetic Biology: Revolutionary or Evolutionary

Synthetic biology has been hailed as a revolution in biotechnology, enabling bold new possibilities in areas such as energy production, medicines, and other applications. But, is it really revolutionary, or just a new tool? With our current knowledge of the structure and function of proteins, the ability for de novo engineering is relatively limited. The […]

Continue Reading